Navigation Links
NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople
Date:2/9/2013

fendants in the interest of judicial efficiency and to avoid duplicative and conflicting legal proceedings.

In such litigations the judge oversees pre-trial evidence-gathering and legal requirements, schedules bellwether cases to allow both plaintiffs and defendants to weigh the strengths and weaknesses of their cases and presides over mediations and settlement discussions.

The judge is also asked to rule on whether such cases should be certified as class-action cases, in which a large pool of plaintiffs are given the choice of whether to remain in the litigation or proceed with their individual case outside of the outcome of the class action.

Resource4thePeople is also providing an information bank in which recent developments in the NuvaRing litigation and information about the popular IUD from medical researchers, news media and the Food and Drug Administration are posted at:

http://www.resource4thepeople.com/defectivedrugs/nuvaring.html

The allegations cited in this multidistrict litigation claim that NuvaRing, described by company officials as the first hormonal IUD, puts women at risk of suffering blood clots that can lead to life-threatening health problems because of the hormone mixture that prevents pregnancies.

The NuvaRing was approved by the Food and Drug Administration in 2001 after being created by Organon BioSciences as a flexible IUD, or ring, hence the name. The IUD releases a low dose of etonogestrel and estrogen over three weeks, providing women the flexibility of a monthly contraceptive.

This flexibility was one of the marketing factors that made the NuvaRing what was described as an easy and healthy contraceptive choice to women who were not satisfied with the side effects caused by birth control pills and the necessity of taking them each day.

However, by 2011 the FDA relea
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
2. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
3. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
4. U-M sibling study discovers genetic region linked to control of key blood-clotting protein
5. Lung Cancer Asbestos Victims Center Now Urges Non Smokers To Call Them If They Now Have Lung Cancer And Were Exposed To Asbestos On The Job-Possible Major Compensation
6. Lung Cancer Asbestos Victims Center Urges Families Of Lung Cancer Victims To Ask The Victim If They Were Exposed To Asbesto On the Job And To Call Them If They Say-Yes
7. Mesothelioma Victims Center Now Fears Most US Nany Veterans Diagnosed With Mesothelioma Get Shortchanged So They Provide The Names Of The Best Mesothelioma Law Firms
8. Lung Cancer Asbestos Victims Center Urges All Individuals Diagnosed With Lung Cancer Who Had On The Job Exposure To Asbestos To Call Them About Financial Compensation
9. US Drug Watchdog Now Urges All Victims Of The Transvaginal Mesh Product Failure With Erosion To Call Them For The Names Of National Caliber Attorneys--Who are all Women
10. US Drug Watchdog Now Expands Their All Metal Hip Implant Initiative By Inviting The Top Personal Injury Law Firms In All States To Help Them Get More Victims Indentified
11. Mesothelioma Victims Center Now Offers Names And Contacts Of The Best Mesothelioma Law Firms For Diagnosed Former Shipyard Workers In CA, WA, VA and Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014 Monica Williams-Murphy MD ... all too well the chaos that can occur for ... “The vast majority of Americans who come into the ... are completely unprepared for the moment and so are ... can serve as a catalyst for a family to ...
(Date:10/31/2014)... With all the preparations families carry ... they may overlook one critical area – the potential ... school performance and even behavior. Typical children’s vision screenings ... progressive vision problems, and to address this challenge, Dr. ... initiative: The Awesome Eyes Student Vision Program. , ...
(Date:10/31/2014)... 2014 (HealthDay News) -- Surgery for low back pain ... the United States you live, a new report says. ... back pain at some point in their lives, and ... care for a spine problem," co-author Brook Martin, of ... said in a college news release. In spinal ...
(Date:10/31/2014)... of treatment and cost, patients with early stage ... irradiation (APBI) with proton therapy versus whole breast ... University of Texas MD Anderson Proton Therapy Center. ... based on typical patient characteristics, researchers used Medicare ... different types of partial and whole breast irradiation ...
(Date:10/31/2014)... a lab device to give cancer researchers an unprecedented ... cells spread through the body, causing more than 90 ... how tumor cells travel, the device could uncover new ... from the university,s Whiting School of Engineering and its ... their new system recently in the journal Cancer ...
Breaking Medicine News(10 mins):Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3
... dose to the breast and lungs before deciding which CT ... new study cautions. The study compared organ doses to ... found a change in protocol could decrease breast radiation dose ... breast skin and parenchyma were found with our standard thoracic ...
... or anxiety states are often associated with disturbances ... are compounds that are released from the synapses ... of neighboring neurons. Thus, as their name suggests, ... serotonin transporter (SERT) is responsible for reuptake of ...
... PROVIDENCE, R.I. Peter J. Snyder, Ph.D., vice president ... 10 Ig Nobel Prize awards during the annual ceremony ... and colleagues from the University of Melbourne and Yale Medical ... acute urge to void the bladder can have the same ...
... at least on the healthy part. "Early to bed and early ... youths keep slimmer and more physically active than their night-owl peers, ... A study in the Oct. 1 issue of the journal ... participants, ages 9 to 16, and compared their weights and uses ...
... New America Media (NAM) have selected 16 reporters for ... in its second year. They represent a wide range of mainstream ... Arizona to Korea Daily Atlanta. The fellows will convene during ... to 22 in Boston and tap into over 500 presentations ...
... -- Working rotating shifts is not as potentially unhealthy ... research that suggests modern shift patterns may not carry ... shift schedules. "Recent research has suggested shift work ... mechanism responsible for this observation is still unknown," the ...
Cached Medicine News:Health News:Combating mood disorders 2Health News:Lifespan researcher wins Ig Nobel Prize 2Health News:Early to bed and early to rise -- study suggests it's keeping kids leaner 2Health News:Journalism fellows promise in-depth portrayal of aging in a diverse America 2Health News:Journalism fellows promise in-depth portrayal of aging in a diverse America 3Health News:Journalism fellows promise in-depth portrayal of aging in a diverse America 4Health News:Modern Shift Work Patterns May Be Less Harmful to Health 2
(Date:10/31/2014)... 31, 2014 Mast Therapeutics, Inc. (NYSE MKT: ... for the quarter ended September 30, 2014. ... said:  "The third quarter was productive for Mast. Consistent with ... MST-188 for sickle cell disease is on track to ... have opened 50 study sites in the U.S. and ...
(Date:10/31/2014)... October 31, 2014 Oramed ... pharmaceutical company focused on the development of oral ... host a conference call to discuss the clinical ... ORMD-0801, the company,s proprietary oral insulin capsules, to ... 2014 at 10:00 a.m. Eastern time. ...
(Date:10/31/2014)... Investor-Edge has initiated coverage on the following ... Pharmaceuticals Inc. (NASDAQ: ISIS ), Halozyme Therapeutics ... (NASDAQ: ACAD ), and Synta Pharmaceuticals Corporation ... be accessed at: http://investor-edge.com/register . On ... 4,566.14, up 0.37%, the Dow Jones Industrial Average advanced ...
Breaking Medicine Technology:Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: